Designed for large-scale vaccine and cell therapy manufacturing, these microcarriers simplify the scale-up of attachment-dependent cells by providing a premeasured, sterile, ready-to-use product for direct transfer into bioreactors. This single-step microcarrier solution replaces several steps traditionally required and allows researchers to minimize lab preparation time and enhance manufacturing results. Offering the Synthemax II and Enhanced Attachment surface treatment options to maximize cell yield and viability, they are fully compatible with closed systems solutions packaging in customizable batch sizes starting at 10g.
Print this page
Related